The Task-force in Europe for Drug Development for the Young (TEDDY) is a Network of Excellence (NoE) funded in 2005 as a consortium responding to a call published by the European Commission and aimed at “structuring efforts devoted to the development of medicines tailored for children”.
Between 2005-2010, the FP6 TEDDY project (LSHB-CT-2005-005216) played a critical role in the start-up of paediatric activities in Europe, in parallel with the introduction of the new European Paediatric Regulation.
Since 2010 TEDDY has revised its organisation and gathered research centres and groups willing to be engaged in developing clinical research. Today, TEDDY is an independent multidisciplinary, multinational Network composed of partners from 15 countries aimed at facilitating the performance of good quality paediatric studies and research.
TEDDY is a category 1 network member of Enpr-EMA, the European Network of Paediatric Research at the European Medicines Agency.
Any research centres and groups willing to be engaged in the development of clinical research can join the TEDDY Network. Find out more.
Latest News
X Foresight Training Course, October 27th-28th, 2017
Also this year the Gianni Benzi Pharmacological Research Foundation organises the annual Foresight Training Course (FTC), at its tenth edition now. The meeting, entitled ‘THE EUROPEAN MEDICINES REGULATORY NETWORK: PRESENT AND FUTURE’, will
ID-EPTRI approval: a great success for paediatric medicines development
We are very pleased to announce that the ID-EPTRI (European Paediatric Translational Research Infrastructure) project, coordinated by CVBF and submitted within the INFRADEV-2016-2017 single-stage call for proposals, aimed to create the framework for
